Anna Salkowska
Lodz, LD 90364, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Targeting IL-17 family cytokines and receptors in hepatocellular carcinoma: From biology to combination immunotherapy.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: February 27, 2026
IL-17B Inhibits Hepatocellular Carcinoma Cell Proliferation.
Journal: Archivum immunologiae et therapiae experimentalis
Published: June 22, 2025
Staphylococcus aureus α-hemolysin induces DNA methylation changes in human Th1 cells.
Journal: Immunologic research
Published: March 03, 2025
Identification of a Novel Indolizine RORγT Inverse Agonist Using the AI-Driven Drug Design Platform.
Identification of a Novel Indolizine RORγT Inverse Agonist Using the AI-Driven Drug Design Platform.
Journal: ACS medicinal chemistry letters
Published: December 10, 2024
α-Hemolysin from Staphylococcus aureus Changes the Epigenetic Landscape of Th17 Cells.
Journal: ImmunoHorizons
Published: July 31, 2024
Epigenetic regulation of the human GDAP1 gene.
Journal: Biochemistry and biophysics reports
Published: July 30, 2024
The cyclin-dependent kinase inhibitor AT7519 is a human RORγt agonist.
Journal: Immunology and cell biology
Published: June 18, 2024
Evaluation of the activity of cardiac glycosides on RORγ and RORγT nuclear receptors.
Journal: Archives of biochemistry and biophysics
Published: February 05, 2024
Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 13, 2023
Chlorpromazine, a Clinically Approved Drug, Inhibits SARS-CoV-2 Nucleocapsid-Mediated Induction of IL-6 in Human Monocytes.
Journal: Molecules (Basel, Switzerland)
Published: April 27, 2022
Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity.
Journal: International journal of molecular sciences
Published: December 24, 2021
Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism.
Journal: International journal of molecular sciences
Published: March 29, 2021
Last Updated: 09/26/2026